Published in J Clin Pathol on September 01, 1977
THE CYTOLOGIC DEMONSTRATION OF BETA-GLUCURONIDASE EMPLOYING NAPHTHOL AS-BI GLUCURONIDE AND HEXAZONIUM PARAROSANILIN; A PRELIMINARY REPORT. J Histochem Cytochem (1964) 3.63
The beta glucuronidase content of human leukocytes in health and in disease. J Lab Clin Med (1952) 2.26
Malignant lymphoma, lymphoblastic. Cancer (1976) 1.75
Chronic lymphocytic leukaemia of T-cell origin. Immunological and clinical evaluation in eleven patients. Lancet (1975) 1.62
Lymphocyte surface characteristics in malignant lymphoma. Am J Med (1975) 1.36
Cytochemical demonstration of beta-glucuronidase activity in blood and bone marrow cells. J Histochem Cytochem (1967) 1.33
Malignant lymphomas of B-cell type. Lancet (1972) 1.27
Clinical significance of T-cells in chronic lymphocytic leukaemia. Lancet (1974) 1.26
Cytochemical profile of B and T leukaemic lymphocytes with special reference to acute lymphoblastic leukaemia. J Clin Pathol (1974) 1.22
Lymphocyte lysosomes and lysosomal enzymes in chronic lymphocytic leukemia. Blood (1973) 1.08
Beta-glucuronidase activity in Sezary cells. Scand J Haematol (1974) 1.05
Similarities of surface characteristics of neoplastic well-differentiated lymphocytes from solid tissues and from peripheral blood. Cancer Res (1976) 1.02
Selective changes in white cell lysosomal enzymes in man. Am J Med Sci (1968) 0.97
Malignant lymphoma, well differentiated lymphocytic: its relationship with chronic lymphocytic leukemia and macroglobulinemia of Waldenström. Cancer (1977) 0.94
The lymphocyte beta-glucuronidase activity in lymphoproliferative disorders. Blood (1968) 0.94
Distribution of acid phosphatase, beta-glucuronidase and N-acetyl-beta-glucosaminise activities in lymphocytes of lymphatic tissues of man and rodents. J Histochem Cytochem (1969) 0.94
The variable pattern of circulating lymphocyte subpopulations in chronic lymphocytic leukemia. N Engl J Med (1976) 0.88
Beta-glucuronidase activity of the white blood cells in human leukemias and Hodgkin's disease. Cancer (1950) 0.85
Letter: T-cell origin of acid-phosphatase-positive lymphoblasts. Lancet (1975) 0.84
Letter: Possible T-cell origin of lymphoblasts in acid-phosphatase-positive acute lymphatic leukaemia. Lancet (1975) 0.81
Cytochemical studies on T and B lymphocytes and lymphoblasts with special reference to acid phosphatase. Acta Haematol (1976) 0.80
[Biochemical and histochemical demonstration of beta-glucuronidase and beta-acetylglucosaminidase in normal and pathological lymph nodes]. Blut (1971) 0.78
[Lysosomal enzymes in blood lymphocytes of normal subjects and patients with chronic lymphadenosis after nonspecific stimulation in vitro of short duration]. Schweiz Med Wochenschr (1970) 0.78
[Cytochemical and immunological determinations in chronic lymphocytic leukemia]. Nouv Rev Fr Hematol (1973) 0.77
A study of lymphocytic beta-glucuronidase in various benign and malignant lymphatic processes. Acta Haematol (1974) 0.77
Hairy cell leukemia: splenectomy after alpha 2b-interferon therapy. Blood (1991) 2.01
Rituximab monotherapy is highly effective in splenic marginal zone lymphoma. Hematol Oncol (2007) 1.75
Microfluorimetric evaluation of cell kill kinetics with 1-beta-D-arabinofuranosylcytosine. Cancer Res (1974) 1.68
Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. European Study Group of CAMPATH-1H Treatment in Chronic Lymphocytic Leukemia. J Clin Oncol (1997) 1.57
Influenza virus vaccine in B-cell chronic lymphocytic leukaemia patients. Acta Haematol (1994) 1.55
Malignant lymphoma arising in angioimmunoblastic lymphadenopathy. Cancer (1978) 1.49
Effect of pamidronate administration on markers of bone turnover and disease activity in multiple myeloma. Eur J Haematol (2000) 1.46
Demonstration of cell surface antigens and their antibodies by the peroxidase-antiperoxidase method. Transplantation (1978) 1.42
Blood and bone marrow findings in angioimmunoblastic lymphadenopathy. Blood (1978) 1.35
On the familial predisposition to favism. Am J Hum Genet (1966) 1.29
Quantitative analysis of flow microfluorometric data from asynchronous and drug-treated cell populations. Comput Biomed Res (1976) 1.21
Prognostic evaluation of the microvascular network in myelodysplastic syndromes. Leukemia (2001) 1.16
Angioimmunoblastic lymphadenopathy. Long-term follow-up study. Cancer (1983) 1.13
Peptide analysis of the inclusions of erythroid cells in beta-thalassemia. Biochim Biophys Acta (1966) 1.11
Clinical approach to lymphadenopathy. Semin Oncol (1993) 1.04
Accumulation of O6-methylguanine in human blood leukocyte DNA during exposure to procarbazine and its relationships with dose and repair. Cancer Res (1990) 0.99
Ectopic production of human chorionic gonadotropin (hCG) by neoplasms: the value of measurements of immunoreactive hCG in the urine as a screening procedure. Cancer (1980) 0.99
Development of plasma cell tumors during treatment of multiple myeloma. Ann Hematol (1996) 0.96
Identification of slow-moving haemoglobins in haemoglobin H disease from different racial groups. Lancet (1972) 0.96
Multiple myeloma associated with autoimmune hemolytic anemia. Haematologica (1994) 0.95
In vivo formation and repair of O6-methylguanine in human leukocyte DNA after intravenous exposure to dacarbazine. Carcinogenesis (1991) 0.94
F-Thalassemia. A study of thirty-one families with simple heterozygotes and combinations of F-Thalassemia with A2-Thalassemia. Am J Med (1969) 0.94
Angiogenesis in Hodgkin's lymphoma: a morphometric approach in 286 patients with prognostic implications. Leukemia (2005) 0.94
Malignant lymphoma, well differentiated lymphocytic: its relationship with chronic lymphocytic leukemia and macroglobulinemia of Waldenström. Cancer (1977) 0.94
Prenatal diagnosis of thalassemia major in Greece: evaluation of the first large series of attempts. Ann N Y Acad Sci (1980) 0.94
A method for the ultrastructural demonstration of non-specific esterase in human blood and lymphoid tissue. Histochem J (1980) 0.93
'Silent' beta-thalassaemia caused by a 'silent' beta-chain mutant: the pathogenesis of a syndrome of thalassaemia intermedia. Br J Haematol (1982) 0.93
Pseudoxanthoma elasticum-like skin lesions and angioid streaks in beta-thalassemia. Am J Hematol (1992) 0.92
Application of a prediction rule to select which patients presenting with lymphadenopathy should undergo a lymph node biopsy. Medicine (Baltimore) (2000) 0.91
Primary non-Hodgkin's lymphoma of the gall bladder. Leuk Lymphoma (2000) 0.90
HLA antigens and Adamantiades-Behçet's disease (A-BD) in Greeks. Clin Exp Rheumatol (1988) 0.89
Cytochemical findings in human nonneoplastic blood and tonsillar B and T lymphocytes. Am J Clin Pathol (1978) 0.89
Clinicopathologic correlations of bone marrow angiogenesis in chronic myeloid leukemia: a morphometric study. Leukemia (2003) 0.89
Serum levels of tetranectin, intercellular adhesion molecule-1 and interleukin-10 in B-chronic lymphocytic leukemia. Clin Biochem (1999) 0.88
Primary effusion lymphoma in two HIV-negative patients successfully treated with pleurodesis as first-line therapy. Anticancer Res (2010) 0.88
Evidence for sinoatrial blockade associated with high dose cytarabine therapy. Leuk Res (1998) 0.87
Structural study of hemoglobin Knossos, beta 27 (B9) Ala leads to Ser. A new abnormal hemoglobin present as a silent beta-thalassemia. FEBS Lett (1982) 0.87
Analysis of the kappa light chain variable region in multiple myeloma. Br J Haematol (1996) 0.87
Acute ("malignant") myelosclerosis. Cancer (1979) 0.87
Hypereosinophilia associated with monosomy 7. Cancer Genet Cytogenet (1995) 0.86
The pattern of hemoglobin precipitation in thalassemia and its significance. Ann N Y Acad Sci (1969) 0.86
Intraerythroblastic instability of hemoglobin beta-4 (Hgb H). Blood (1968) 0.86
The origin of the sickle mutation in Greece; evidence from beta S globin gene cluster polymorphisms. Hemoglobin (1991) 0.86
Acid hydrolases in normal B and T blood lymphocytes. Acta Haematol (1978) 0.85
Polyadenylic acid polymerase activity in normal and leukemic human leukocytes. Cancer Res (1984) 0.85
Terminal transferase in leukemia of adults. Acta Haematol (1979) 0.85
Adhesion molecules in B-chronic lymphoproliferative disorders. Semin Hematol (1999) 0.85
An electron microscopic study of the nuclear abnormalities in erythroblasts in beta-thalassaemia major. Br J Haematol (1974) 0.85
B-chronic lymphocytic leukemia. Prognostic implication of bone marrow histology in 120 patients experience from a single hematology unit. Cancer (1987) 0.85
Prolymphocytic leukemia: clinical, histopathological, and cytochemical observations. Cancer (1978) 0.85
'Fetal' erythropoiesis following bone marrow transplantation as estimated by the number of F cells in the peripheral blood. Bone Marrow Transplant (1994) 0.84
Tuberculosis associated hemophagocytic syndrome complicated with severe bone marrow failure and disseminated intravascular coagulation. Nouv Rev Fr Hematol (1992) 0.84
Serum interleukin-10 levels are an independent prognostic factor for patients with Hodgkin's lymphoma. Haematologica (2001) 0.84
Prenatal diagnosis of thalassemia and Hb S syndromes in Greece: an evaluation of 1500 cases. Ann N Y Acad Sci (1985) 0.83
High serum levels of B-lymphocyte stimulator are associated with clinical-pathological features and outcome in classical Hodgkin lymphoma. Br J Haematol (2007) 0.83
Molecular analysis of transferrin receptor mRNA expression in acute myeloid leukaemia. Br J Haematol (2001) 0.83
Imprint cytology of non-Hodgkin's lymphomas based on a study of 212 immunologically characterized cases: correlation of touch imprints with tissue sections. Hum Pathol (1989) 0.83
Anterior pituitary function in the Prader-Labhart-Willi (PLW) syndrome. J Clin Endocrinol Metab (1974) 0.82
HLA antigens and otosclerosis. A possible new genetic factor. Arch Otolaryngol (1982) 0.82
Coexistence of Behcet's disease and chronic myelomonocyte leukemia with trisomy 8: a case report and review of the literature. Clin Exp Rheumatol (2009) 0.81
Molecular analysis of immunoglobulin genes in multiple myeloma. Leuk Lymphoma (1999) 0.81
Angio-immunoblastic lymphadenopathy terminating as Hodgkin's disease. Cancer (1977) 0.81
Low incidence of acute myocardial infarction in beta-thalassaemia trait carriers. Haematologia (Budap) (1995) 0.81
Acute myeloid leukemia in a patient with ataxia-telangiectasia: a case report and review of the literature. Leukemia (2001) 0.81
Ultrastructure of the inclusion bodies and nuclear abnormalities in beta-thalassemic erythroblasts. Ann N Y Acad Sci (1974) 0.81
Lactate dehydrogenase isoenzyme pattern in sera of patients with malignant diseases. Clin Chem (1989) 0.81
Extramedullary blast crisis in chronic myelogenous leukemia presenting with manifestations of cauda equina syndrome. Haematologica (1988) 0.81
Addition of cyclosporin-A to chemotherapy in secondary (post-MDS) AML in the elderly. A multicenter randomized trial of the Leukemia Working Group of the Hellenic Society of Hematology. Ann Hematol (2006) 0.81
Prognostic relevance of apoptotic cell death in non-Hodgkin's lymphomas: a multivariate survival analysis including Ki67 and p53 oncoprotein expression. Histopathology (1998) 0.81
Waldenström's macroglobulinemia: clinical course and prognostic factors in 60 patients. Experience from a single hematology unit. Ann Hematol (2001) 0.80
Prognostic implications of proliferating cell nuclear antigen (PCNA), AgNORs and P53 in non-Hodgkin's lymphomas. Leuk Lymphoma (1998) 0.80
DNA, RNA and hemoglobin during erythroblast maturation. A cytophotometric study. Exp Cell Res (1970) 0.80
Somatic hypermutation of immunoglobulin variable region genes: focus on follicular lymphoma and multiple myeloma. Immunol Rev (1998) 0.80
The beta-delta thalassemias. Ann N Y Acad Sci (1969) 0.79
Detection of CD55 and/or CD59 deficient red cell populations in patients with aplastic anaemia, myelodysplastic syndromes and myeloproliferative disorders. Haematologia (Budap) (2001) 0.79
A case of spinal cord compression by extramedullary haemopoiesis in a thalassaemic patient: a putative role for hydroxyurea? Haematologica (1992) 0.79
Hemoglobin Knossos: a clinical, laboratory, and epidemiological study. Am J Hematol (1986) 0.79
Simultaneous PML/RAR alpha and AML 1/ETO gene rearrangements in a patient with acute myeloid leukemia. Leukemia (1999) 0.79
Acute lymphoblastic leukemia: the significance of nuclear convolutions. Cancer (1979) 0.79
HLA antigens and congenital dislocation of the hip. Tissue Antigens (1983) 0.79
An immunocytochemical study of non-Hodgkin's lymphomas. Cancer (1981) 0.79
Common clonal origin of lymphoplasmacytic proliferation and immunoblastic lymphoma in intestinal alpha-chain disease. Lancet (1977) 0.79
FLT3 overexpression in acute promyelocytic leukemia patients without detectable FLT3-ITD or codon 835-836 mutations: a pilot study. Anticancer Res (2006) 0.79
Correction of disease related anaemia of B-chronic lymphoproliferative disorders by recombinant human erythropoietin: maintenance is necessary to sustain response. Leuk Lymphoma (2000) 0.78
Hemoglobins of early human embryonic development. Science (1966) 0.78
Poly(A)-polymerase activity in chronic lymphocytic leukemia of the B cell type. Acta Haematol (1985) 0.78
Recurrent attacks of hemolytic uremic syndrome. Haematologia (Budap) (1991) 0.78
Proteolysis in thalassemia: studies with protease inhibitors. Ann N Y Acad Sci (1980) 0.78
RNase H of human leukemic cells: a new biological parameter in the study of human leukemias (review). Anticancer Res (1990) 0.78
p16INK4A is regularly expressed in Hodgkin's disease: comparison with retinoblastoma, p53 and MDM2 protein status, and the presence of Epstein-Barr virus. Mod Pathol (1999) 0.78